Latest Dynavax Technologies Corporation Stories
ReportsnReports.com adds Hepatitis B Global Clinical Trials Review H2 2014 to its store.
Findings Could Lead to Lower Doses of Medication for Lupus Patients, Reducing Serious Side Effects DALLAS, July 12 /PRNewswire-USNewswire/ -- Two immune system proteins could be the culprit behind many lupus patients' resistance to widely used steroid treatments, scientists with the Baylor Research Institute (BRI) in Dallas announced today.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.